What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Infectious Disease

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1182117

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1182117

Global Levofloxacin Market Size study & Forecast, by Application (Pneumonia, Skin Infection, Kidney Infection, Bladder Infection, Other Applications), and Regional Analysis, 2022-2029

PUBLISHED: November 16, 2022

PAGES:

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Global Levofloxacin Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Levofloxacin is an antibiotic used to kill germs within the body that is sold under the trade name Levaquin. Levofloxacin and other fluoroquinolone antimicrobials block DNA gyrase and topoisomerase IV in bacteria as part of their mechanism of action. It is offered as a tablet and as an injectable medication. This medication is used to diagnose several illnesses, including acute bacterial sinusitis, chronic prostatitis, urinary tract infections, and pneumonia. The market growth is driven by the growing Incidence of Bacterial Infections and the rising number of Baby Boomers are the key factors responsible for the market growth.

The World Health Organization's Global Tuberculosis Report 2021 states that in October 2021, South-East Asia (43%), Africa (25%), and the Western Pacific (18%) had the highest numbers of tuberculosis cases, while the Eastern Mediterranean (8.3%), Americas (3.0%), and Europe (2.3% had the lowest percentages. Statistics show that the prevalence of tuberculosis is high worldwide, which is considered to boost market expansion because Levofloxacin is frequently used to treat the disease. However, a lack of Awareness Associated with Infectious diseases stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Levofloxacin Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is dominating the worldwide revenue owing to technological advancements and the increasing prevalence of chronic diseases. However, Asia Pacific is expected to be the fastest-growing region in the forecast years due to major expansion in manufacturing pharmacies.

Major market players included in this report are:

Dr. Reddy's Laboratories Ltd

Aden Healthcare

Alna Biotech Private Limited

Divine Savior Pvt LtdAllenge India Pharma

Glenmark Pharmaceuticals Limited

Zydus Cadila

Lupin Limited

Bestochem

PAX Healthcare

Recent Developments in the Market:

In February 2022, the Indian pharmaceutical conglomerate Dr. Reddy's Laboratories and Binnopharm Group, a major Russian drug producer through its affiliate Alium, announced the signing of an agreement that will allow Binnopharm Group to purchase antibacterial drugs from Dr. Reddy's in Russia, Uzbekistan, and Belarus under the Ciprolet (ciprofloxacin) and Levolet (levofloxacin) brands.
NTC and Aspen will report SAHPRA-satisfactory results for the fixed-dose combination of levofloxacin and dexamethasone multidose eye in November 2021.

Global Levofloxacin Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Application, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Pneumonia

Skin Infection

Kidney Infection

Bladder Infection

Other Applications

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Levofloxacin Market, by region, 2019-2029 (USD Billion)
- 1.2.2. Levofloxacin Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Levofloxacin Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Levofloxacin Market Dynamics

3.1. Levofloxacin Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Growing Incidence of Bacterial Infections
  - 3.1.1.2. Rising Number of Baby Boomers
- 3.1.2. Market Challenges
  - 3.1.2.1. Lack of Awareness Associated with Infectious Disease
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising government initiatives with an objective of improving awareness about diagnosis
  - 3.1.3.2. Rising number of hospitals and retail pharmacies

Chapter 4. Global Levofloxacin Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Levofloxacin Market, by Application

6.1. Market Snapshot
6.2. Global Levofloxacin Market by Application, Performance - Potential Analysis
6.3. Global Levofloxacin Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
6.4. Levofloxacin Market, Sub Segment Analysis
- 6.4.1. Pneumonia
- 6.4.2. Skin Infection
- 6.4.3. Kidney Infection
- 6.4.4. Bladder Infection
- 6.4.5. Other Applications

Chapter 7. Global Levofloxacin Market, Regional Analysis

7.1. Levofloxacin Market, Regional Market Snapshot
7.2. North America Levofloxacin Market
- 7.2.1. U.S. Levofloxacin Market
  - 7.2.1.1. Application breakdown estimates & forecasts, 2019-2029
- 7.2.2. Canada Levofloxacin Market
7.3. Europe Levofloxacin Market Snapshot
- 7.3.1. U.K. Levofloxacin Market
- 7.3.2. Germany Levofloxacin Market
- 7.3.3. France Levofloxacin Market
- 7.3.4. Spain Levofloxacin Market
- 7.3.5. Italy Levofloxacin Market
- 7.3.6. Rest of Europe Levofloxacin Market
7.4. Asia-Pacific Levofloxacin Market Snapshot
- 7.4.1. China Levofloxacin Market
- 7.4.2. India Levofloxacin Market
- 7.4.3. Japan Levofloxacin Market
- 7.4.4. Australia Levofloxacin Market
- 7.4.5. South Korea Levofloxacin Market
- 7.4.6. Rest of Asia Pacific Levofloxacin Market
7.5. Latin America Levofloxacin Market Snapshot
- 7.5.1. Brazil Levofloxacin Market
- 7.5.2. Mexico Levofloxacin Market
7.6. Rest of The World Levofloxacin Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Company Profiles
- 8.2.1. Dr. Reddy's Laboratories Ltd
  - 8.2.1.1. Key Information
  - 8.2.1.2. Overview
  - 8.2.1.3. Financial (Subject to Data Availability)
  - 8.2.1.4. Product Summary
  - 8.2.1.5. Recent Developments
- 8.2.2. Aden Healthcare
- 8.2.3. Alna Biotech Private Limited
- 8.2.4. Divine Savior Pvt Ltd
- 8.2.5. Allenge India Pharma
- 8.2.6. Glenmark Pharmaceuticals Limited
- 8.2.7. Zydus Cadila
- 8.2.8. Lupin Limited
- 8.2.9. Bestochem
- 8.2.10. PAX Healthcare

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Levofloxacin Market, report scope
TABLE 2. Global Levofloxacin Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Levofloxacin Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 4. Global Levofloxacin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Levofloxacin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Levofloxacin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Levofloxacin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Levofloxacin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Levofloxacin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Levofloxacin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Levofloxacin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Levofloxacin Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Levofloxacin Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Levofloxacin Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Levofloxacin Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Levofloxacin Market
TABLE 69. List of primary sources, used in the study of global Levofloxacin Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered